We believe that the decrease in PACAP levels with age favors the development of the disease, during which plasma cells have an adverse impact on the microenvironment, causing a subsequent drop in peptide levels and a corresponding decline in tumor control. This evidence concerns the gene ADCYAP1 and neoplasm.